Albert Arredondo Jr., MSN, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 4301 Mow-way Rd, Rach (attn:mcua-qc, Ms. Prescott), Fort Sill, OK 73505 Phone: 580-458-2134 Fax: 580-458-2314 |
Mark Sistoso, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 4301 Wilson St, Fort Sill, OK 73503 Phone: 719-205-0017 |
News Archive
Chemists at Hong Kong Baptist University have discovered the use of a metal compound that inhibits the enzyme closely associated with triple-negative breast cancer, one of the most difficult forms of breast cancer to treat.
GenSpera, Inc. (OTCQB:GNSZ) announced that the first patient was enrolled in the Phase II clinical trial of its lead compound, G-202, in patients who have glioblastoma multiforme (GBM), the most prevalent type of primary brain cancer.
Oxford University researchers are closer to solving a decade-old mystery after discovering that a set of genes they are studying play a key role in early human development.
An environmental scientist, who led medical waste treatment during the 2014 Ebola outbreak in West Africa, says that COVID-19 is one of the "easiest pathogens to destroy" and hospitals need not resort to environmentally unfriendly incineration to dispose of biomedical waste piling up from treating those infected with the virus.
The MEDICREA Group, a company that specializes in the development of personalized implants produced for a patient's specific need in the treatment of spinal pathologies, today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration for UNiD, the world's first patient-specific spinal osteosynthesis rod.
› Verified 3 days ago